Figure 9From: Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approachesPrediction of dose response for trough FEV 1 at steady state in typical patient with moderate or severe COPD according to the predefined GOLD criteria.Back to article page